DocDollars

Genmab A/S

Denmark · Reporting entity ID 100001351951

Total reported 2019–2025
$33.4M
#220 of 2,960 reporting companies — 0% of all reported industry payments
$34K in general payments across 10 records, plus $33.3M in research funding across 6,554 records.

How it breaks down

General payments $34,411
Research funding $33,318,296

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Genmab A/S reported $33.4M to US doctors and teaching hospitals from 2019 to 2025, ranking #220 of 2,960 reporting companies. 100% of that was research funding and 0% general payments such as consulting, speaking, food and travel. 10 general payment records and 6,554 research records were filed.

Common questions about Genmab A/S

How much has Genmab A/S paid US doctors?

Genmab A/S reported $33,352,707 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $34,411 in general payments, $33,318,296 in research funding.

How does Genmab A/S rank among drug and device companies?

It ranks #220 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Genmab A/S mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.